- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-7083
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The impact of CBP expression in estrogen receptor-positive breast cancer ; volume:13 ; number:1 ; day:7 ; month:4 ; year:2021 ; pages:1-18 ; date:12.2021
Clinical epigenetics ; 13, Heft 1 (7.4.2021), 1-18, 12.2021
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13148-021-01060-2
- URN
-
urn:nbn:de:101:1-2021052908214227471253
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ramadan, Wafaa S.
- Talaat, Iman M.
- Hachim, Mahmood Y.
- Lischka, Annette
- Gemoll, Timo
- El-Awady, Raafat
- SpringerLink (Online service)
Ähnliche Objekte (12)
microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer
Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers
Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer
microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer
Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers
Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer
microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer
Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers